Weibin Wang

2.2k total citations · 1 hit paper
86 papers, 1.5k citations indexed

About

Weibin Wang is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, Weibin Wang has authored 86 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Oncology, 34 papers in Molecular Biology and 23 papers in Surgery. Recurrent topics in Weibin Wang's work include Pancreatic and Hepatic Oncology Research (31 papers), MicroRNA in disease regulation (10 papers) and Pancreatitis Pathology and Treatment (8 papers). Weibin Wang is often cited by papers focused on Pancreatic and Hepatic Oncology Research (31 papers), MicroRNA in disease regulation (10 papers) and Pancreatitis Pathology and Treatment (8 papers). Weibin Wang collaborates with scholars based in China, Germany and United States. Weibin Wang's co-authors include Yupei Zhao, Bangbo Zhao, Gang Yang, Qin Cheng, Lei You, Huanyu Wang, Fangyu Zhao, Guangyu Chen, Bo Ren and Jinshou Yang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Hepatology and Annals of Surgery.

In The Last Decade

Weibin Wang

80 papers receiving 1.5k citations

Hit Papers

Metabolism of pancreatic cancer: paving the way to better... 2020 2026 2022 2024 2020 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Weibin Wang China 21 758 575 502 235 230 86 1.5k
Alessio Giubellino United States 21 605 0.8× 308 0.5× 329 0.7× 236 1.0× 119 0.5× 77 1.3k
Yulong Shang China 22 1.2k 1.6× 761 1.3× 309 0.6× 177 0.8× 267 1.2× 55 1.8k
Tsuyoshi Osawa Japan 21 1.0k 1.3× 448 0.8× 292 0.6× 116 0.5× 137 0.6× 37 1.4k
Mingxuan Feng China 16 857 1.1× 488 0.8× 210 0.4× 113 0.5× 126 0.5× 48 1.3k
Bisheng Zhou China 21 924 1.2× 399 0.7× 302 0.6× 82 0.3× 160 0.7× 41 1.4k
Omar M. Rashid United States 25 786 1.0× 450 0.8× 738 1.5× 241 1.0× 99 0.4× 68 1.7k
Lei Deng China 19 1.1k 1.4× 956 1.7× 242 0.5× 99 0.4× 179 0.8× 33 1.5k
Marta Herreros‐Villanueva Spain 24 999 1.3× 477 0.8× 845 1.7× 231 1.0× 219 1.0× 51 1.8k
Scott K. Kuwada United States 24 535 0.7× 230 0.4× 554 1.1× 442 1.9× 118 0.5× 67 1.7k

Countries citing papers authored by Weibin Wang

Since Specialization
Citations

This map shows the geographic impact of Weibin Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weibin Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weibin Wang more than expected).

Fields of papers citing papers by Weibin Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weibin Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weibin Wang. The network helps show where Weibin Wang may publish in the future.

Co-authorship network of co-authors of Weibin Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Weibin Wang. A scholar is included among the top collaborators of Weibin Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weibin Wang. Weibin Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Zhou, Ling, Weihao Liang, Cheng Xiao, et al.. (2025). Identification of Clinically Significant Portal Hypertension in cACLD Individuals With Spleen Stiffness Measurement. Liver International. 45(4). e16241–e16241. 1 indexed citations
3.
4.
Qin, Cheng, et al.. (2025). RNA binding protein Pumilio2 promotes chemoresistance of pancreatic cancer via focal adhesion pathway and interacting with transcription factor EGR1. Cellular and Molecular Life Sciences. 82(1). 78–78. 1 indexed citations
5.
Li, Tianyu, Zhen Cao, Lin Chen, & Weibin Wang. (2025). Global Burden of Thyroid Cancer in Children and Adolescents, 1990–2021: Trends, Disparities, and Future Projections. Cancers. 17(5). 892–892.
6.
Lu, Junliang, Liangrui Zhou, Taiping Zhang, et al.. (2025). Molecular profiling reveals the malignant potential in solid pseudopapillary neoplasms of the pancreas. Cancer Letters. 625. 217788–217788. 1 indexed citations
7.
Wang, Yuanyang, Yutong Zhao, Bangbo Zhao, et al.. (2025). Extracellular vesicles-miR-205-5p inhibits lymphatic metastasis in pancreatic cancer through diffusely downregulating VEGFA. Journal of Cancer. 16(7). 2197–2211.
8.
Li, Tianyu, Dongming Zhang, Jiashu Han, et al.. (2025). Evaluating the surgical and oncological outcomes of hepatic artery variations in minimally invasive pancreaticoduodenectomy: insights from 2023 data at a high-volume pancreatic center. World Journal of Surgical Oncology. 23(1). 44–44. 1 indexed citations
9.
Li, Tianyu, Cheng‐Feng Qin, Bangbo Zhao, et al.. (2024). Global and regional burden of pancreatitis: epidemiological trends, risk factors, and projections to 2050 from the global burden of disease study 2021. BMC Gastroenterology. 24(1). 398–398. 18 indexed citations
10.
Li, Tianyu, et al.. (2024). Goal-oriented preoperative biliary drainage is more precise and conducive to seize the opportunity for pancreaticoduodenectomy. World Journal of Surgical Oncology. 22(1). 331–331. 2 indexed citations
11.
Li, Tianyu, Bangbo Zhao, Xiaoying Yang, et al.. (2023). Risk stratification of clinically relevant delayed gastric emptying after pancreaticoduodenectomy. BMC Surgery. 23(1). 222–222. 7 indexed citations
12.
Wang, Yuanyang, Cheng‐Feng Qin, Bangbo Zhao, et al.. (2023). EGR1 induces EMT in pancreatic cancer via a P300/SNAI2 pathway. Journal of Translational Medicine. 21(1). 201–201. 27 indexed citations
13.
Zhao, Bangbo, Cheng‐Feng Qin, Zeru Li, et al.. (2022). Multidrug resistance genes screening of pancreatic ductal adenocarcinoma based on sensitivity profile to chemotherapeutic drugs. Cancer Cell International. 22(1). 374–374. 10 indexed citations
14.
Li, Tianhao, Cheng‐Feng Qin, Bangbo Zhao, et al.. (2021). Identification METTL18 as a Potential Prognosis Biomarker and Associated With Immune Infiltrates in Hepatocellular Carcinoma. Frontiers in Oncology. 11. 665192–665192. 13 indexed citations
15.
Yang, Yan, Jiansheng Xiao, Weibin Wang, et al.. (2021). Alterations of thyroid microbiota across different thyroid microhabitats in patients with thyroid carcinoma. Journal of Translational Medicine. 19(1). 488–488. 26 indexed citations
16.
Li, Yongyin, Libo Tang, Ling Guo, et al.. (2019). CXCL13-mediated recruitment of intrahepatic CXCR5+CD8+ T cells favors viral control in chronic HBV infection. Journal of Hepatology. 72(3). 420–430. 77 indexed citations
17.
Gong, Jianan, Jianxiong Li, Yi Wang, et al.. (2013). Characterization of microRNA-29 family expression and investigation of their mechanistic roles in gastric cancer. Carcinogenesis. 35(2). 497–506. 79 indexed citations
18.
Xu, Lai, Weibin Wang, Yupei Zhao, et al.. (2012). Medullary thyroid carcinoma with nodular goiter carries an excellent prognosis. Journal of Surgical Oncology. 106(2). 169–173. 7 indexed citations
19.
Wang, Weibin. (2007). A Study on Superior Tree Selection of Taxus wallichiana. 2 indexed citations
20.
Wang, Weibin. (2006). Biological and Ecological Characteristics of Taxus yunnanensis. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026